Results 11 to 20 of about 23,386 (218)

Advanced Ovarian Dysgerminoma With Supraclavicular Lymph Node Metastasis and Peritoneal Carcinomatosis: A Rare Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Ovarian dysgerminoma is a rare, highly chemo‐sensitive germ cell tumor usually presenting early. We report a FIGO stage IVB case with supraclavicular lymph node metastasis and peritoneal carcinomatosis in a 31‐year‐old woman. Diagnosis was based on classical histopathology.
Khaniya B   +5 more
europepmc   +2 more sources

Diagnostic value of positron emission tomography/computed tomography (PET/CT) in detection of peritoneal carcinomatosis

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2023
Background The diagnosis of peritoneal carcinomatosis is challenging and can be difficult to detect with imaging, especially the detection of small-sized peritoneal lesions. The presence of peritoneal neoplastic spread alters tumour staging and is one of
Ahmed Abdelmonem Darweesh   +3 more
doaj   +1 more source

Role of Computed Tomography in the Evaluation of Peritoneal Carcinomatosis

open access: yesJournal of the Belgian Society of Radiology, 2023
Peritoneal carcinomatosis (PC) refers to metastatic spread of tumor into the peritoneal cavity. Earlier, PC was thought to be associated with grave clinical outcome.
Snehal Kose
doaj   +1 more source

Diagnosis of Peritoneal Carcinomatosis of Colorectal Origin Based on an Innovative Fuzzy Logic Approach

open access: yesDiagnostics, 2022
Colorectal cancer represents one of the most important causes worldwide of cancer related morbidity and mortality. One of the complications which can occur during cancer progression, is peritoneal carcinomatosis. In the majority of cases, it is diagnosed
Valentin Bejan   +2 more
doaj   +1 more source

The role of computed tomography in planning surgical treatment of peritoneal dissemination from ovarian carcinoma [PDF]

open access: yesMedicinski Podmladak, 2015
Introduction: Ovarian carcinomas primarily disseminate within the peritoneal cavity which their in the first line treatment is surgical. To make surgical treatment successful, it includes cytoreductive surgery and intraperitoneal chemotherapy.
Janković Katarina, Janićijević Jelena
doaj   +1 more source

Pathophysiology of elevated ascites fluid cholesterol in malignant ascites [PDF]

open access: yes, 1992
The existence of marked elevations of ascitic fluid cholesterol has been observed in patients with peritoneal carcinomatosis compared to patients with cirrhosis and has been found useful in differential diagnosis.
Alexander L. Gerbes   +27 more
core   +1 more source

Peritoneal Tuberculosis Mimicking Peritoneal Carcinomatosis

open access: yesCase Reports in Medicine, 2014
A 67-year-old male presented with fatigue, abdominal pain , and 30-pound weight loss over 3 months. Computerized tomography (CT) abdomen displayed ascites with thickening and enhancement of the peritoneum and mottled nodular appearing as soft tissue consistent with omental caking worrisome for peritoneal carcinomatosis.
Mehmet Akce   +3 more
openaire   +4 more sources

Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis [PDF]

open access: yes, 2015
BACKGROUND: Peritoneal metastasis (PM) is considered a terminal and incurable disease. In the last 30 years, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically changed the therapeutic approach for these patients ...
Accarpio, Fabio   +8 more
core   +2 more sources

Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer [PDF]

open access: yes, 2019
Patients with advanced ovarian cancer develop recurrence despite initial treatment response to standard treatment of surgery and intravenous/intraperitoneal (IP) chemotherapy, partly due to a limited peritoneal exposure time of chemotherapeutics ...
Ceelen, Wim   +7 more
core   +2 more sources

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Peritoneal carcinomatosis is a fatal clinical presentation of colon cancer, characterized by unresponsiveness to conventional anticancer therapies, including immune checkpoint inhibitors.
Jeong Hun Kim   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy